Literature DB >> 3774695

Surgical treatment of hypertrophic cardiomyopathy (Düsseldorf experience).

W Bircks.   

Abstract

Surgical treatment appears to be the therapy of choice in hypertrophic, obstructive cardiomyopathy, at least in patients who are in the advanced stage of the disease and refractory to medical treatment. In addition, strong evidence has been obtained that surgical treatment improved the prognosis at least in patients who required only a myectomy via a transaortic approach.

Entities:  

Mesh：

Year:  1986        PMID： 3774695      PMCID： PMC2418767          DOI： 10.1136/pgmj.62.728.571

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  4 in total

1.  SURGICAL TREATMENT AND POST-OPERATIVE HAEMODYNAMIC STUDIES IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY.

Authors:  H H BENTALL; W P CLELAND; C M OAKLEY; P M SHAH; R E STEINER; J F GOODWIN
Journal:  Br Heart J       Date:  1965-07

2.  Arrhythmias in hypertrophic obstructive and non-obstructive cardiomyopathy.

Authors:  M Borggrefe; H Kuhn; H H Königer; H Stöter; G Breithardt; F Loogen; H D Schulte; W Bircks
Journal:  Eur Heart J       Date:  1983-11       Impact factor: 29.983

3.  Exercise performance in hypertrophic cardiomyopathies.

Authors:  B Lösse; H Kuhn; F Loogen; H D Schulte
Journal:  Eur Heart J       Date:  1983-11       Impact factor: 29.983

4.  Surgical aspects of typical subaortic and atypical midventricular hypertrophic obstructive cardiomyopathy (HOCM).

Authors:  H D Schulte; W Bircks; R Körfer; H Kuhn
Journal:  Thorac Cardiovasc Surg       Date:  1981-12       Impact factor: 1.827
  4 in total
  1 in total

Review 1.  Percutaneous transluminal septal myocardial ablation.

Authors:  D N Rubin; E M Tuzcu; H M Lever
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 3.955
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.